drugset / Trial / NCT00343642
Dietary Treatment of Crohn's Disease
Phase 1/2
Completed
73 enrolled
Rush University Medical Center
National Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedSingle-groupTriple-blindTreatment
Summary
Our objective is to determine whether a specific dietary intervention or a fructooligosaccharide (FOS) supplement has anti-oxidant or prebiotic effects and whether it is beneficial in the treatment of Crohn's Disease (CD.
Timeline
- Start
- 2006-09
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fructooligosaccharide | Unknown | 2 unknown | Oral |